PHARMACEUTICAL COMPOSITION COMPRISING HMG-CoA REDUCTASE INHIBITOR, TOCOPHEROL AND CoQ10

摘要

PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for simultaneously preventing or treating (1) hyperuricemia or diseases caused thereby, (2) vascular endothelial dysfunction and/or vascular endothelial cell-derived blood nitrogen monoxide level drop and (3) hyperlipemia or diseases caused thereby. SOLUTION: The pharmaceutical composition comprises an HMG-CoA reductase inhibitor, a tocopherol, and ubidecarenone. COPYRIGHT: (C)2008,JPO&INPIT